Recon: FDA approves GSK’s Boostrix to prevent whooping cough in infants; EU Commission targets Teva for alleged anticompetitive practices

ReconReconBiologicsBiotechnologyDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy